v3.25.1
Consolidated Statements of Operations (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]        
Revenue $ 1,254,966 $ 343,894 $ 3,348,220 $ 639,286
Operating expenses:        
Cost of revenue 413,085 233,585 1,312,209 385,491
Research and development 470,979 620,285 1,140,114 2,106,253
General and administrative 1,202,372 452,792 2,069,149 1,721,820
Total operating expenses 2,086,436 1,306,662 4,521,472 4,213,564
Loss from operations (831,470) (962,768) (1,173,252) (3,574,278)
Other income (expense):        
Interest income 2,558 198 2,761 879
Other expense (81) (81)
Amortization of discount on convertible notes (287,298) (715,117)
Changes in fair value of derivative liabilities 2,577,103 (277,942)
Total other income (expense), net 2,292,363 117 (990,298) 798
Income (loss) before income tax expense 1,460,893 (962,651) (2,163,550) (3,573,480)
Income tax expense
Net income (loss) $ 1,460,893 $ (962,651) $ (2,163,550) $ (3,573,480)
Net income (loss) per share:        
Loss per share - basic (in Dollars per share) $ 0.12 $ (0.08) $ (0.18) $ (0.29)
Diluted (in Dollars per share) $ 0.11 $ (0.08) $ (0.18) $ (0.29)
Weighted average common shares outstanding:        
Basic (in Shares) 12,472,061 12,175,195 12,286,284 12,338,041
Weighted average common shares outstanding - diluted (in Shares) 13,206,919 12,175,195 12,286,284 12,338,041

Source